argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 584.80
-8.40 (-1.42%)
At close: Mar 20, 2026
argenx SE Market Cap
argenx SE has a market cap or net worth of €36.29 billion as of March 20, 2026. Its market cap has increased by 10.45% in one year.
Market Cap
36.29B
Enterprise Value
32.55B
Revenue
3.61B
Ranking
n/a
PE Ratio
35.09
Stock Price
€584.80
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 36.29B, an increase of 29,547.07%. That is a compound annual growth rate of 62.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 36.29B | -17.26% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 47.97B |
| Financière de Tubize | 9.41B |
| Onward Medical | 196.31M |
| Hyloris Pharmaceuticals | 162.40M |
| European Medical Solutions | 20.74M |
| Celyad Oncology | 14.06M |
| BioSenic | 1.50M |
| Oxurion NV | 392.55K |